CFD and metabolic dysfunction-associated steatohepatitis: Complement factor D, the rate limiting step of the alternative pathway of complement activation, may act as an adipokine, thus linking tissue homeostasis and metabolic regulation in chronic liver diseases like non-alcoholic steatohepatitis (NASH) [76,77].